Laboratory criteria for menopause in women using oral contraceptives

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Objective: To evaluate laboratory criteria for menopause in women taking oral contraceptives (OC). Design: Prospective, uncontrolled pilot study. Setting: San Francisco General Hospital, San Francisco, California, and Magee-Womens Hospital, Pittsburgh, Pennsylvania. Patients: Twenty-eight menopausal women. Interventions: Fourteen menopausal women received triphasic 35 μg ethinyl E2 and 180-215-250 μg norgestimate, and 14 menopausal women received monophasic 30 μg ethinyl E2150 μg desogestrel. Main Outcome Measures: Serum FSH, LH, and E2 levels were evaluated on days 14 and 28 (day 7 of the pill-free interval) of the third cycle of pills. Results: Twelve women in each group completed the study. Fifteen (62.5%) subjects still had a serum FSH <30 mIU/mL (30 IU/L) on the 7th day of the pill-free interval of the third pill package. All subjects had a serum FSH:LH ratio >1 and 20 of 21 (95%) subjects had E2 < 20 pg/mL (73 pmol/L) at the end of the pill-free interval of the third cycle. Conclusions: Measuring FSH on the 7th day of the pill-free interval is not a sensitive test for menopause. Serum FSH:LH ratio >1 or E2 < 20 pg/mL (73 pmol/L) on the 7th day of the pill-free interval may be a more appropriate marker of menopause in women using OC in the later reproductive years.

Original languageEnglish (US)
Pages (from-to)101-104
Number of pages4
JournalFertility and Sterility
Volume66
Issue number1
StatePublished - 1996
Externally publishedYes

Fingerprint

Oral Contraceptives
Menopause
San Francisco
Desogestrel
Serum
General Hospitals
Outcome Assessment (Health Care)

Keywords

  • E
  • FSH
  • LH
  • menopause
  • Oral contraceptives

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Laboratory criteria for menopause in women using oral contraceptives. / Creinin, Mitchell D.

In: Fertility and Sterility, Vol. 66, No. 1, 1996, p. 101-104.

Research output: Contribution to journalArticle

@article{9348957ca9164576a84f587bf494d589,
title = "Laboratory criteria for menopause in women using oral contraceptives",
abstract = "Objective: To evaluate laboratory criteria for menopause in women taking oral contraceptives (OC). Design: Prospective, uncontrolled pilot study. Setting: San Francisco General Hospital, San Francisco, California, and Magee-Womens Hospital, Pittsburgh, Pennsylvania. Patients: Twenty-eight menopausal women. Interventions: Fourteen menopausal women received triphasic 35 μg ethinyl E2 and 180-215-250 μg norgestimate, and 14 menopausal women received monophasic 30 μg ethinyl E2150 μg desogestrel. Main Outcome Measures: Serum FSH, LH, and E2 levels were evaluated on days 14 and 28 (day 7 of the pill-free interval) of the third cycle of pills. Results: Twelve women in each group completed the study. Fifteen (62.5{\%}) subjects still had a serum FSH <30 mIU/mL (30 IU/L) on the 7th day of the pill-free interval of the third pill package. All subjects had a serum FSH:LH ratio >1 and 20 of 21 (95{\%}) subjects had E2 < 20 pg/mL (73 pmol/L) at the end of the pill-free interval of the third cycle. Conclusions: Measuring FSH on the 7th day of the pill-free interval is not a sensitive test for menopause. Serum FSH:LH ratio >1 or E2 < 20 pg/mL (73 pmol/L) on the 7th day of the pill-free interval may be a more appropriate marker of menopause in women using OC in the later reproductive years.",
keywords = "E, FSH, LH, menopause, Oral contraceptives",
author = "Creinin, {Mitchell D}",
year = "1996",
language = "English (US)",
volume = "66",
pages = "101--104",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Laboratory criteria for menopause in women using oral contraceptives

AU - Creinin, Mitchell D

PY - 1996

Y1 - 1996

N2 - Objective: To evaluate laboratory criteria for menopause in women taking oral contraceptives (OC). Design: Prospective, uncontrolled pilot study. Setting: San Francisco General Hospital, San Francisco, California, and Magee-Womens Hospital, Pittsburgh, Pennsylvania. Patients: Twenty-eight menopausal women. Interventions: Fourteen menopausal women received triphasic 35 μg ethinyl E2 and 180-215-250 μg norgestimate, and 14 menopausal women received monophasic 30 μg ethinyl E2150 μg desogestrel. Main Outcome Measures: Serum FSH, LH, and E2 levels were evaluated on days 14 and 28 (day 7 of the pill-free interval) of the third cycle of pills. Results: Twelve women in each group completed the study. Fifteen (62.5%) subjects still had a serum FSH <30 mIU/mL (30 IU/L) on the 7th day of the pill-free interval of the third pill package. All subjects had a serum FSH:LH ratio >1 and 20 of 21 (95%) subjects had E2 < 20 pg/mL (73 pmol/L) at the end of the pill-free interval of the third cycle. Conclusions: Measuring FSH on the 7th day of the pill-free interval is not a sensitive test for menopause. Serum FSH:LH ratio >1 or E2 < 20 pg/mL (73 pmol/L) on the 7th day of the pill-free interval may be a more appropriate marker of menopause in women using OC in the later reproductive years.

AB - Objective: To evaluate laboratory criteria for menopause in women taking oral contraceptives (OC). Design: Prospective, uncontrolled pilot study. Setting: San Francisco General Hospital, San Francisco, California, and Magee-Womens Hospital, Pittsburgh, Pennsylvania. Patients: Twenty-eight menopausal women. Interventions: Fourteen menopausal women received triphasic 35 μg ethinyl E2 and 180-215-250 μg norgestimate, and 14 menopausal women received monophasic 30 μg ethinyl E2150 μg desogestrel. Main Outcome Measures: Serum FSH, LH, and E2 levels were evaluated on days 14 and 28 (day 7 of the pill-free interval) of the third cycle of pills. Results: Twelve women in each group completed the study. Fifteen (62.5%) subjects still had a serum FSH <30 mIU/mL (30 IU/L) on the 7th day of the pill-free interval of the third pill package. All subjects had a serum FSH:LH ratio >1 and 20 of 21 (95%) subjects had E2 < 20 pg/mL (73 pmol/L) at the end of the pill-free interval of the third cycle. Conclusions: Measuring FSH on the 7th day of the pill-free interval is not a sensitive test for menopause. Serum FSH:LH ratio >1 or E2 < 20 pg/mL (73 pmol/L) on the 7th day of the pill-free interval may be a more appropriate marker of menopause in women using OC in the later reproductive years.

KW - E

KW - FSH

KW - LH

KW - menopause

KW - Oral contraceptives

UR - http://www.scopus.com/inward/record.url?scp=0029992925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029992925&partnerID=8YFLogxK

M3 - Article

C2 - 8752618

AN - SCOPUS:0029992925

VL - 66

SP - 101

EP - 104

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 1

ER -